Serving patients is a privilege that comes with responsibilities...
Protect patient safety by sharing information and developing processes related to the integrity of the healthcare supply chain and the quality of materials within the supply chain
Rx-360 White Paper on Illegal Diversion of Pharmaceuticals: contextualize the causes and impact of illegal diversion with case studies specific to this issue. Successful mitigation strategies for illegal diversion within the global pharmaceutical supply chain will be highlighted. To read the White paper go to:
Rx-360 White Paper on Mitigating Risk to the Supply Chain - Drug Shortage Working Group reviews some potential mitigation steps for companies to consider if they have a drug shortage to prevent criminals from exploiting the shortage. To read the White paper go to:
Rx-360 Congratulates FDA and Deb Autor for Developing and Sharing Counterfeit Detectors to Aid Battle Against Malaria
Deborah M. Autor
Somewhere right now, malaria patients facing a life-threatening illness are being treated with counterfeit or substandard anti-malarial drugs, including falsified products, that threaten their recovery and can contribute to drug resistance. We are proud to announce the Food and Drug Administration’s launch of a partnership that will use a clever, innovative tool invented by FDA scientists to quickly and cheaply test suspect counterfeit or substandard anti-malarial drugs, including falsified products. The partnership will test the effectiveness of this hand-held, battery-operated tool, called Counterfeit Detection Device, Version 3, or, simply, CD-3. It will be deployed first in Ghana and then, after data is collected, in a second testing region. Read More
Rx-360 Rleases New Smart Phone APP for Android Phones, IPads and IPhones
Today, Rx-360 is proud to announce the launch of IPad and IPhone Apps that provide everything that you may need to know about the pharmaceutical supply chain and the quality of material within the supply chain.
A Thought Provoking Article Aimed at Reducing Shortages
"Economic and technological drivers of generic sterile injectable drug shortages"
Over the past few years, an increasing number of critically needed medicines have been in short supply. Using economic theory to frame the drug-shortage problem, this paper explores why and how manufacturing-quality problems could combine with other economic and technological factors to result in shortages of generic sterile injectable drugs.
To read the entire article, click here
Come to the workshop to learn about supply chain security during interesting and entertaining presentations such as the recent presentation on Counterfeiting at the PDA Annual Meeting, whcih can be watched below:
Join Our Members and Your Colleagues Protecting Patients
it is now time for decisive action.
Join Rx-360 Today!
To View or Download the Presentation
Click on the Slide Above
To see other presentations, click here
Additional Resources to Help Fight for Patient Safety
(To Read More, Click on the Title of the Article Below)
Register for Free
Summary of Supply Chain
and Material Alerts Issued
Supply Chain Security
Past Issues of
Rx-360 Flash Reports
Past Rx-360 Summaries of